AMC
WhiteOak Capital Mutual Fund
Category
Sectoral Fund
ISIN
INF03VN01878

WhiteOak Capital Pharma and Heathcare Fund

₹15.5970

−₹0.1230 (−0.78%)

NAV · Regular · Growth ·

WhiteOak Capital Pharma and Heathcare Fund's Regular Growth NAV was ₹15.5970 on 21 Oct 2026, down 0.78% on the day. Its 1-year return is 11.32%.

52-week NAV range9.1% below high
₹12.9310₹17.1650
Expense ratio
2.80%
Fund size
₹857.84 Cr
Min. investment
₹500

Between 23 Oct 2025 and 21 Oct 2026, the NAV ranged from ₹12.9310 to ₹17.1650.

Regular · Growth plan. 3Y, 5Y and since-launch returns are annualised; since launch is absolute until the fund is a year old. Longer ranges appear once the fund has that much history.

Fund details

Expense ratio
2.80% (Regular)
Exit load
nil
Riskometer
Very high
Benchmark
BSE Healthcare TRI
Launched
16 Jan 2024
Fund managers
Ramesh Mantri, Ashish Agrawal, Trupti Agrawal, Dheeresh Pathak, Piyush Baranwal

Fund size, expense ratio and minimums as of 16 Oct 2026.

All plans

PlanISINNAV1 dayExpense ratio1 year
Direct · GrowthINF03VN01886₹16.4770−0.91%1.11%+13.27%
Regular · GrowthINF03VN01878₹15.5970−0.78%2.80%+11.32%

All plans hold the same portfolio. They differ in expense ratio (Direct plans pay no distributor commission) and in how gains are handled (Growth reinvests, IDCW pays out).

Armor risk check

WhiteOak Capital Pharma and Heathcare Fund moves about as much as the market

Volatility, past year

This fund13%
Nifty 50015%

Worst fall, past year

This fund−9%
Nifty 500−15%

Compared with the Nifty 500 over the past 12 months.

Check it against your portfolio in the app

About this fund

WhiteOak Capital Pharma and Heathcare Fund is an open-ended mutual fund from WhiteOak Capital Mutual Fund, in the Sectoral Fund category. It began on 16 Jan 2024. It is benchmarked to the BSE Healthcare TRI. The fund manages ₹857.84 Cr across its plans as of 16 Oct 2026. The Regular · Growth plan has an expense ratio of 2.80%. The minimum first investment is ₹500, and SIPs are available.

FAQs

What is the NAV of WhiteOak Capital Pharma and Heathcare Fund?

The NAV of WhiteOak Capital Pharma and Heathcare Fund (Regular · Growth) was ₹15.5970 on 21 Oct 2026, down 0.78% from the previous NAV.

What plans does WhiteOak Capital Pharma and Heathcare Fund have?

WhiteOak Capital Pharma and Heathcare Fund has 2 plans: Direct · Growth; Regular · Growth.

What is the expense ratio of WhiteOak Capital Pharma and Heathcare Fund?

The Regular · Growth plan of WhiteOak Capital Pharma and Heathcare Fund has an expense ratio of 2.80%.

What is the fund size (AUM) of WhiteOak Capital Pharma and Heathcare Fund?

WhiteOak Capital Pharma and Heathcare Fund manages ₹857.84 Cr across all plans as of 16 Oct 2026.

What returns has WhiteOak Capital Pharma and Heathcare Fund delivered?

WhiteOak Capital Pharma and Heathcare Fund returned +11.32% over 1Y. Past performance does not guarantee future returns.

What is the exit load of WhiteOak Capital Pharma and Heathcare Fund?

WhiteOak Capital Pharma and Heathcare Fund: nil.

What is the minimum investment and SIP amount for WhiteOak Capital Pharma and Heathcare Fund?

The minimum first investment in WhiteOak Capital Pharma and Heathcare Fund is ₹500, and ₹500 after that. SIPs are available (SIP available Daily/Weekly/Fortnightly/Monthly/Quarterly. Minimum: Rs.100 for Daily/Weekly/Fortnightly/Monthly, Rs.500 for Quarterly. Minimum instalments: 6 for Daily/Weekly/Fortnightly/Monthly, 4 for Quarterly.).

How risky is WhiteOak Capital Pharma and Heathcare Fund?

WhiteOak Capital Pharma and Heathcare Fund is rated "very high risk" on SEBI's riskometer.

For information only. Not investment advice or a research report. Past performance does not guarantee future returns. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.

Full disclaimer

See how WhiteOak Capital Pharma and Heathcare Fund fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app